Evidence map›Paper›PMID 34451488›Full record

ArticlePathogens (Basel, Switzerland)2021

Cranberry (

Mattia Mirandola, Maria Vittoria Salvati, Carola Rodigari, K Sofia Appelberg, Ali Mirazimi, Massimo E Maffei, Giorgio Gribaudo, Cristiano Salata

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mattia MirandolaDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.ORCID 0000-0001-7145-3443
Maria Vittoria SalvatiDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
Carola RodigariDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
K Sofia AppelbergDepartment of Microbiology, Public Health Agency of Sweden, 17182 Solna, Sweden.
Ali MirazimiDepartment of Microbiology, Public Health Agency of Sweden, 17182 Solna, Sweden.
Massimo E MaffeiDepartment of Life Sciences and Systems Biology, University of Turin, 10123 Turin, Italy.ORCID 0000-0001-6814-2353
Giorgio GribaudoDepartment of Life Sciences and Systems Biology, University of Turin, 10123 Turin, Italy.ORCID 0000-0002-1583-9146
Cristiano SalataDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.ORCID 0000-0002-5136-7406
University of Padua · ITPublic Health Agency of Sweden · SEUniversity of Turin · IT

Funding

Università degli Studi di Padova DOR-2019 and DOR-2020
6 · The paper itself

Abstract

Hazara virus (HAZV) belongs to the

Indexed as

A-type proanthocyanidinsCrimean-Congo hemorrhagic fever virusHazara virusVaccinum macrocarpon extractvirucidal and antiviral activities

Identifiers

PMID34451488
PMCPMC8401317
OpenAlexW3195921979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.